StockData
Aktis Oncology, Inc. logo

Aktis Oncology, Inc. (AKTS) SEC filings

AKTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$16.16−0.46 (-2.77%)

Close on Nov 16, 2026Market cap $898.81MP/E –Yield –

SEC filings

10 of Aktis Oncology's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 12, 2026SEC EDGAR
Current report8-KNov 12, 2026Nov 12, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 13, 2026SEC EDGAR
Current report8-KAug 13, 2026Aug 13, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 11, 2026SEC EDGAR
Current report8-KMay 11, 2026May 11, 2026SEC EDGAR
Current report8-KApr 15, 2026Apr 16, 2026SEC EDGAR
Current report8-KMar 30, 2026Mar 30, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 30, 2026SEC EDGAR
Current report8-KJan 12, 2026Jan 12, 2026SEC EDGAR

See a number that looks wrong?